iSelect Fund Management

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

PopBookings is a cloud-based staffing solution company that specializes in automating the hiring process for temporary and promotional staffing agencies. Founded in 2014 and headquartered in Lenexa, Kansas, PopBookings offers a comprehensive platform designed to simplify the booking and communication with promotional staff. Its features include database management, a custom-branded talent portal, drag-and-drop scheduling, geo check-ins, and an event dashboard with status alerts. By connecting agencies and brands with event workers, PopBookings facilitates the organization of events, helping to celebrate brands through effective staffing solutions.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

Kultevat, Inc. is a biotechnology company focused on the breeding and cultivation of industrially relevant dandelion varieties, specifically the Russian Dandelion, to serve as a sustainable source of natural rubber. Founded in 2013 and based in Portageville, Missouri, the company engages in the processing and extraction of dandelion rubber and related co-products, offering latex and bulk rubber products for various applications, including gloves, medical devices, automotive parts, and biofuels. Kultevat aims to provide an environmentally friendly alternative to synthetic rubber, contributing to reduced ecological impact while serving agricultural markets in the United States, Canada, and Europe. Its innovative approach combines crop improvement and strain selection to enhance the performance and versatility of natural rubber.

Epharmix, Inc. is a digital healthcare company that specializes in developing clinically validated, condition-specific communication tools designed for the healthcare industry. Founded in 2015 and based in St. Louis, Missouri, the company creates digital interventions tailored to various patient populations, aimed at enhancing patient-physician engagement. Epharmix's products facilitate the automatic collection of clinical data over time, which allows for algorithmic alerts to healthcare providers, thereby supporting chronic care management for patients. By focusing on underserved patient groups, Epharmix enables care teams to improve healthcare delivery while reducing workload through proven interventions that enhance both engagement and health outcomes.

Euclises Pharmaceuticals, Inc. is a biopharmaceutical company focused on researching, developing, and commercializing innovative medicines for inflammation and oncology. Founded in 2011 and headquartered in Saint Louis, Missouri, the company aims to create novel pain and cancer treatments that demonstrate superior safety profiles compared to existing medications. Euclises Pharmaceuticals leverages groundbreaking inventions from Dr. John Talley, a renowned medicinal chemist known for his development of several approved drugs, including Celebrex. The company's research is centered on compounds that promise enhanced efficacy and safety, positioning Euclises as a significant player in the pharmaceutical industry. It operates out of the BioGenerator Accelerator Labs, fostering a collaborative environment for its innovative pursuits.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

Ward Alternative Energy was born from a passion to provide American, low cost, clean transportation fuels for vehicles. Discovering, producing and compressing natural gas in the field is a deep upstream expertise built over the past 50 years at Ward Petroleum. At Ward Alternative Energy, we add the down-stream natural gas, fueling and NGV expertise of our industry veterans. Our team is well prepared to be the natural gas fuels, station services and vehicle services provider and partner of choice for fleets. We started our business in Colorado in 2012 but are now expanding to Wyoming, New Mexico, northwest Texas and east through Kansas to St. Louis.

BenchmarkONE is a St. Louis, Missouri-based company that specializes in developing sales and marketing automation software for small and mid-sized businesses. Founded in 2010 and previously known as Hatchbuck, Inc., BenchmarkONE provides an all-in-one customer relationship management (CRM) platform that includes features for sales automation, real-time activity monitoring, and email marketing. Its user-friendly interface allows businesses to create and manage campaigns, track leads, and analyze performance metrics effectively. The software is designed to streamline the sales process, enhance customer engagement, and facilitate the growth of relationships into sales. As of June 2020, BenchmarkONE operates as a subsidiary of Benchmark Internet Group, LLC.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

Kultevat, Inc. is a biotechnology company focused on the breeding and cultivation of industrially relevant dandelion varieties, specifically the Russian Dandelion, to serve as a sustainable source of natural rubber. Founded in 2013 and based in Portageville, Missouri, the company engages in the processing and extraction of dandelion rubber and related co-products, offering latex and bulk rubber products for various applications, including gloves, medical devices, automotive parts, and biofuels. Kultevat aims to provide an environmentally friendly alternative to synthetic rubber, contributing to reduced ecological impact while serving agricultural markets in the United States, Canada, and Europe. Its innovative approach combines crop improvement and strain selection to enhance the performance and versatility of natural rubber.

ImmunoPhotonics, Inc. is a biotechnology company focused on developing innovative immunotherapy-based treatments for cancer, specifically targeting metastatic solid tumors. Founded in 2008 and headquartered in Columbia, Missouri, the company has created a proprietary drug product that functions as a minimally invasive autologous cancer vaccine. This treatment involves the intratumoral injection of a carbohydrate polymer following tumor ablation, which harnesses the immune system's response to tumor-associated neoantigens released during the process. By doing so, ImmunoPhotonics aims to generate a systemic anti-tumor immune response, facilitating the treatment of late-stage metastatic cancers. The company has established a strategic partnership with Veterinary Cancer Therapeutics, LLC, enhancing its potential for clinical application.

CrazyForEducation LLC, founded by Dr. Renato Cataldo in 2012 and based in St. Louis, Missouri, specializes in developing online teaching software and educational tools aimed at enhancing the learning experience for schools, teachers, students, and professionals. The company offers a comprehensive platform designed for flip teaching, which includes tools for lesson assignments, student note-taking, course management, and assessment tracking. Additionally, CrazyForEducation provides professional development for educators, featuring recorded webinars and resources tailored for school districts. Its uTutor.me platform allows users to access and replay video lessons from K-12 and college educators, while ClinPharmEd serves clinical pharmacists and pharmacy students with a video-sharing service for educational content. Through its innovative solutions, CrazyForEducation aims to empower educators and facilitate adaptive teaching models that enhance student learning.

adFreeq, LLC is a personalized classified advertisement platform that connects buyers and sellers in real-time. Founded in 2011 and headquartered in Columbia, Missouri, the company offers the adFreeq adPortal, a versatile JavaScript widget or WordPress plug-in designed for publishers, including online newspapers, media companies, and blogs. This platform allows publishers to seamlessly embed classified advertisements into their websites without the need for hardware or software installation. AdFreeq's self-managed, cloud-based service aggregates personalized classified ads from various sources, including social media and local to national publishers, facilitating a comprehensive browsing experience for users. With additional locations in the United States and China, adFreeq aims to streamline the classified ad process while enhancing accessibility for both advertisers and consumers.

adFreeq, LLC is a personalized classified advertisement platform that connects buyers and sellers in real-time. Founded in 2011 and headquartered in Columbia, Missouri, the company offers the adFreeq adPortal, a versatile JavaScript widget or WordPress plug-in designed for publishers, including online newspapers, media companies, and blogs. This platform allows publishers to seamlessly embed classified advertisements into their websites without the need for hardware or software installation. AdFreeq's self-managed, cloud-based service aggregates personalized classified ads from various sources, including social media and local to national publishers, facilitating a comprehensive browsing experience for users. With additional locations in the United States and China, adFreeq aims to streamline the classified ad process while enhancing accessibility for both advertisers and consumers.

Tansna Therapeutics, Inc. is a drug discovery and development company focused on creating innovative oral medications for the treatment of epilepsy and other central nervous system disorders. Established in 2010 and headquartered in St. Louis, Missouri, the company is dedicated to developing novel therapies aimed at improving the lives of patients suffering from debilitating conditions. Its main product in development is an oral anticonvulsant agent designed to effectively reduce seizure frequency in individuals with epilepsy, providing healthcare professionals with enhanced treatment options for their patients.

Tansna Therapeutics, Inc. is a drug discovery and development company focused on creating innovative oral medications for the treatment of epilepsy and other central nervous system disorders. Established in 2010 and headquartered in St. Louis, Missouri, the company is dedicated to developing novel therapies aimed at improving the lives of patients suffering from debilitating conditions. Its main product in development is an oral anticonvulsant agent designed to effectively reduce seizure frequency in individuals with epilepsy, providing healthcare professionals with enhanced treatment options for their patients.